Stockscreener 앱 받기
0.00
100.00%
-1.26
전일 마감가:
$1.26
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$8.60M
수익:
$129.20K
순이익/손실:
$-7.44M
주가수익비율:
0.00
EPS:
-11.19
순현금흐름:
$-8.62M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
명칭
Sonnet Biotherapeutics Holdings Inc
전화
609-375-2227
주소
100 OVERLOOK CENTER, PRINCETON, NJ
SONN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
0.00 | 8.60M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sonnet Biotherapeutics Holdings Inc 주식(SONN)의 최신 뉴스
Will Sonnet BioTherapeutics Holdings Inc. stock maintain growth storyTrade Signal Summary & Real-Time Market Sentiment Reports - DonanımHaber
Why Sonnet BioTherapeutics Holdings Inc. stock is a must watch in 2025Market Weekly Review & Precise Entry and Exit Recommendations - Улправда
Sonnet BioTherapeutics (NASDAQ: SONN) updates FHAB-based oncology pipeline - Stock Titan
Sonnet BioTherapeutics Holdings: Net loss of $16.0M on $1.0M revenue, with urgent need for new funding to sustain operations - TradingView — Track All Markets
Sonnet BioTherapeutics (NASDAQ:SONN) Shares Down 67.3% – Here’s Why - Defense World
What analysts say about Sonnet BioTherapeutics Holdings Inc stockMarket Timing Techniques & Low Cost Wealth Building - earlytimes.in
Lowenstein Represents Sonnet BioTherapeutics In Closing Of Business Combination With Hyperliquid Strategies - Mondaq
Officer Kenney Acquires 233,374 Of Sonnet BioTherapeutics Holdings Inc [SONN] - TradingView
Hyperliquid Strategies Moves $411M in HYPE to Hypercore - Live Bitcoin News
Sonnet BioTherapeutics Stockholders Greenlight Hyperliquid Strategies Merger Deal - Blockonomi
Sonnet’s $1B Hype Treasury Signals Ambitious Digital Asset Expansion After Merger Approval - Crypto Economy
Sonnet BioTherapeutics Merges with Hyperliquid Strategies - TipRanks
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for hedge fundsWeekly Trend Summary & Real-Time Buy Zone Alerts - Newser
Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock: Merges Into Hyperliquid Era with Nasdaq Debut as PURR - parameter.io
Sonnet BioTherapeutics Enters a New Frontier with a $1 Billion HYPE Digital Asset Treasury - OneSafe
Biotech Trio Gets Hammered On Heavy Trading - Finimize
Sonnet BioTherapeutics shareholders approve proposed business merger with Hyperliquid Strategies Inc. - Bitget
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination - GlobeNewswire
Hyperliquid (HYPE) May Revisit $59 Soon Amid Extreme Market Fear: Here is Why - Coinpedia Fintech News
HYPE news live: price surges after merger nod — faces resistance at $36.22, range-bound outlook - Traders Union
Sonnet BioTherapeutics Approves Merger with Hyperliquid and Rorschach - MSN
Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock: Shareholders Approve Hyperliquid Merger, Setting Stage for $1B HYPE Treasury - CoinCentral
Revolutionary Shift: How Sonnet BioTherapeutics Became a $305M Digital Asset Treasury Powerhouse - CryptoRank
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Sonnet shareholders approve Hyperliquid merger to launch HYPE-focused crypto treasury - Crypto Briefing
Stockholders Approve Sonnet–Hyperliquid Merger - citybiz
Sonnet shareholders approve merger for potential $1 billion HYPE crypto treasury - The Block
Sonnet BioTherapeutics (SONN) Stockholders Approve Business Comb - GuruFocus
Sonnet Biotherapeutics Holdings announces stockholder approval of proposed business combination with Hyperliquid Strategies - marketscreener.com
Sonnet BioTherapeutics shareholders approve business combination - Investing.com
Sonnet BioTherapeutics shareholders approve business combination By Investing.com - Investing.com Australia
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder Approval of Business Combination - TradingView
Sonnet BioTherapeutics Stockholders Approve Business Combination with Hyperliquid Strategies Inc and Rorschach I LLC - Quiver Quantitative
Sonnet BioTherapeutics Holdings, Inc. Announces Stockholder - GlobeNewswire
Sonnet BioTherapeutics (NASDAQ: SONN) gets stockholder OK for Hyperliquid Strategies business combination - Stock Titan
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for passive investorsJuly 2025 Rallies & Stepwise Entry/Exit Trade Alerts - Newser
Hyperliquid Strategies Inc Announces David Schamis as Chief Executive Officer - marketscreener.com
Sonnet BioTherapeutics (SONN) Stock Analysis Report | Financials & Insights - Benzinga
Sonnet BioTherapeutics Holdings, Inc.(NasdaqCM:SONN) dropped from NASDAQ Composite Index - marketscreener.com
What drives Sonnet BioTherapeutics Holdings Inc stock priceTrading Psychology Tips & Start Learning With Our Courses - earlytimes.in
Can Sonnet BioTherapeutics Holdings Inc. stock maintain growth trajectoryMarket Risk Summary & Breakout Confirmation Trade Signals - moha.gov.vn
Healthy Upside Potential: Sonnet BioTherapeutics Holdings Inc (SONN) - setenews.com
Sonnet BioTherapeutics (NASDAQ:SONN) Shares Up 3.2% – Should You Buy? - Defense World
Regression analysis insights on Sonnet BioTherapeutics Holdings Inc. performanceMarket Sentiment Report & AI Based Trade Execution Alerts - newser.com
Why Sonnet BioTherapeutics Holdings Inc. stock could benefit from AI revolution2025 Market Outlook & Weekly High Conviction Ideas - newser.com
Published on: 2025-11-20 06:58:46 - newser.com
Hyperliquid Treasury Merger Vote Delayed, Postponing $888 Million Deal - Tekedia
Is Sonnet BioTherapeutics Holdings Inc. stock a buy on dipsSell Signal & Precise Swing Trade Entry Alerts - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock rebound after recent weaknessJuly 2025 EndofMonth & Long-Term Safe Investment Ideas - newser.com
Is Sonnet BioTherapeutics Holdings Inc. stock a good choice for value investors2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - newser.com
Can Sonnet BioTherapeutics Holdings Inc. stock outperform in 2025 bull market - newser.com
Sonnet Biotherapeutics Holdings Inc (SONN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.31%
0.33%
자본화:
|
볼륨(24시간):